OR26-03 Treatment With Linsitinib, An IGF-1 Receptor Inhibitor, Prevents Disease Development And Progression In An Experimental Model Of Thyroid Eye Disease

Disclosure: A. Gulbins: Grant Recipient; Self; Sling therapeutics, Inc. M. Horstmann: Grant Recipient; Self; Sling therapeutics, Inc. A. Daser: None. U. Flögel: None. M. Oeverhaus: Grant Recipient; Self; Sling therapeutics, Inc. B.E. Nikolaos: None. J.P. Banga: None. G. Krause: None. G.D. Hammer: Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulbins, Anne, Horstmann, Mareike, Daser, Anke, Flögel, Ulrich, Oeverhaus, Michael, Nikolaos, Bechrakis E, Paul Banga, J, Krause, Gerd, Hammer, Gary D, Spencer, Andrew G, Zeidan, Ryan, Eckstein, Anja, Philipp, Svenja, Görtz, Gina-Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555290/
http://dx.doi.org/10.1210/jendso/bvad114.2052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555290/
http://dx.doi.org/10.1210/jendso/bvad114.2052

Ejemplares similares